PROfylactic Haloperidol in Patients Defined as High Risk for DElirium With Delirium Risk mOdel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The hospital pharmacy at the Zuyderland Medical Centre developed the DElirium MOdel (DEMO) to predict which patients are at risk of developing a delirium in patients aged 60 or older. With this delirium risk prediction model we aim to predict more accurately which patients are at high risk of developing a delirium and want to investigate if these patients can benefit from prophylactic haloperidol.
Epistemonikos ID: 214f0c6d5bea78f745c5d6c64d6f67fe6bec0c0c
First added on: May 20, 2024